Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery

References

• Julkunen M, Koistinen R, Aalto-Setälä M, Jänne OA, Kontula K. Primary structure of human insulin-like growth factor binding protein/placental protein 12 and tissue expression of its mRNA. FEBS Lett 1988; 236: 295–302.
   Google Scholar
• Rutanen E-M, Bohn H, Seppälä M. Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women and patients with trophoblastic disease. Am J Obstet Gynecol 1982; 144: 460–3.
   Google Scholar
• Martina NA, Kim E, Chitkara U, Wathen NC, Chard T, Giudice LC. Gestational age-dependent expression of insulin-like growth factor binding protein-1 (IGFBP-1) phosphoforms in human extraamniotic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab 1997; 82: 1894–8.
   Google Scholar
• Nuutila M, Hiilesmaa V Kärkkäinen T, Ylikorkala O, Rutanen E-M. Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol 1999; 94: 243–9.
   Google Scholar
• Rutanen E-M, Kärkkäinen T, Lundqvist C et al. Monoclonal antibodies to the 27–34K insulin-like growth factor binding protein. Biochem Biophys Res Commun 1988; 152: 208–15.
   Google Scholar
• Rutanen E-M, Kärkkäinen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen AL. Evaluation of rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1996; 253: 91–101.
   Google Scholar
• Kekki M, Kurki T, Paavonen J, Rutanen E-M. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet 1999; 353: 1494.
   Google Scholar
• Hurley R. Infections in pregnancy. In: Turnbull Sir A, Chamberlein G (eds.): Obstetrics. Edinburgh: Churchill Livingstone, 1989: 623–40.
   Google Scholar
• Lockwood C, Seneyel A, Dische M et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669–74.
   Google Scholar
• Nageotte M, Casal D, Senyei A. Fetal fibronectin in patients at increased risk for preterm birth. Am J Obstet Gynecol 1994; 170: 20–5.
   Google Scholar
• Chevouny PH, Pankuch GA, Romero R, Botti JJ, Kuhn DC, Demers LK et al. Neutrophil attractant/activating peptide-1/interleukin-8: Association with histologic chor- ioamnionitis, preterm delivery and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993; 169(5): 1299–303.
   Google Scholar
• Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Cherv- enak FA et al. Detection of tumor necrosis factor-a, interleukin-6 and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome. Am J Obstet Gynecol 1994; 171: 5–10.
   Google Scholar
• Ascarelli MH, Morrison JC. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997; 52: 1–12.
   Google Scholar
• Faron G, Boulvain M, Lescrainier JP, Vokaer A. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators? Br J Obstet Gynaecol 1997; 104: 697–701.
   Google Scholar
• Hellemans P, Gerris J, Verdonk P Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995; 102: 207–12.
   Google Scholar
• Kurki T, Ylikorkala O. Coitus during pregnancy is not related to bacterial vaginosis or preterm birth. Am J Obstet Gynecol 1993; 169: 1130–4.
   Google Scholar
• Lockwood CJ, Kuczynski E. Markers of the risk for preterm delivery. J Perinat Med 1999; 27: 5–20.
   Google Scholar
• Rutanen E-M, Pekonen F, Kärkkäinen T. Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: Comparison with the ROM-check membrane immunoassay in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1993; 214: 73–81.
   Google Scholar